Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2

Coronavirus disease 2019 (COVID-19) has affected millions of people worldwide. During the early stages of vaccination in Egypt, the ChAdOx1 nCoV-19 and BBIBP-CorV vaccines were the most distributed. The aim of this study was to compare the immune responses and short-term efficacies of these two vacc...

詳細記述

書誌詳細

主要な著者:	Ahmed Samir Abdelhafiz, Asmaa Ali, Mahmoud M. Kamel, Eman Hasan Ahmed, Douaa M. Sayed, Rania M. Bakry
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2022-09-01
シリーズ:	Vaccines
主題:	COVID-19 SARS-CoV-2 Egypt ChAdOx1 nCoV-1 BBIBP-CorV
オンライン･アクセス:	https://www.mdpi.com/2076-393X/10/9/1462
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!